Hims & Hers Health Inc. Class A (HIMS)
NYSE: HIMSHealth CareMedical/Nursing ServicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
HIMS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $6.89B
- Forward P/E
- 40.07
- EPS (TTM)
- -$0.64
- Dividend yield
- None
- 52-week range
- 13.74 – 65.30
- Day range
- 28.75 – 29.92
- Volume / Avg
- 5.45M / 12.06M
- Beta
- —
- Shares outstanding
- 224.94M
- Next earnings
- Nov 2, 2026
52-week range
HIMS stock today
On Oct 7, HIMS ended the session at $29.54, adding $0.07 (0.24%), versus the S&P 500's 0.22% decline. Trading was light, with 5.45M shares changing hands, about 45% of the average daily volume. Shares are 54.8% below their 52-week high of $65.30, set on Oct 15, 2025 and 115.0% above the 52-week low of $13.74, in the middle of the past year's range.
HIMS is down 9.0% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 49.0%. Hims & Hers Health has posted a net loss over the last twelve months (EPS of -$0.64), so its P/E ratio is not meaningful. Hims & Hers Health's next earnings report is expected on Nov 2, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Hims & Hers Health
Company profileHims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- CEO
- Mr. Andrew Dudum
- Headquarters
- San Francisco, CA
- Employees
- 2,442
- IPO year
- 2019
- Website
- hims.com
Financial highlights
Full financialsIn fiscal 2025, Hims & Hers Health generated $2.35 billion in revenue, up 59.0% from fiscal 2024, its 6th consecutive year of revenue growth. Net income was $128.4 million (+1.8% year over year), for a net margin of 5.5% versus a median of -12.2% in the prior 5 years. Gross margin was 73.8% (down from 79.5%) and operating margin 4.5%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $2.35B | $1.48B | $872.00M | $526.92M | $271.88M |
| Growth | +59.00% | +69.33% | +65.49% | +93.81% | +82.77% |
| Net income | $128.37M | $126.04M | $-23.55M | $-65.68M | $-107.66M |
| EPS (diluted) | $0.51 | $0.53 | $-0.11 | $-0.32 | $-0.58 |
Analyst forecast
ForecastConsensus (15 analysts)
hold
Avg. price target
$31.15+5.45%
- Strong buy 2
- Buy 1
- Hold 11
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 2, 2026
- EPS estimate
- $0.07
- Last reported (Q2 2026)
- Aug 10, 2026
- EPS actual vs est.
- $-0.37 vs —
HIMS news
All HIMS newsHims & Hers Health peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LFSTLifeStance Health Group Inc. | 12.11 | -0.08% | $4.60B | vs HIMS |
| AVAHAveanna Healthcare Holdings Inc. | 12.31 | +0.74% | $2.69B | vs HIMS |
| PRVAPrivia Health Group Inc. | 20.30 | +0.10% | $2.59B | vs HIMS |
| ADUSAddus HomeCare Corporation | 113.27 | +0.10% | $2.12B | vs HIMS |
| WGSGeneDx Holdings Corp. Class A | 68.53 | -4.18% | $2.04B | vs HIMS |
| BTSGBrightSpring Health Services Inc. | 63.80 | +0.08% | $12.62B | vs HIMS |
| ALPSALPS Group Inc | 0.3444 | -10.71% | $57.31M | vs HIMS |
| EUDAEUDA Health Holdings Limited | 19.04 | -0.58% | $57.01M | vs HIMS |
Indexes, lists and sector
Hims & Hers Health stock FAQ
What is Hims & Hers Health's stock price today?
HIMS last traded at $29.54 as of Oct 7, 4:00 PM EDT, up 0.24% on the day. Prices are delayed at least 15 minutes.
When is Hims & Hers Health's next earnings date?
Hims & Hers Health is expected to report earnings on Monday, November 2, 2026. Analysts expect EPS of $0.07.
Who is Hims & Hers Health's CEO?
Mr. Andrew Dudum is the chief executive officer of Hims & Hers Health Inc. Class A, which has about 2,442 employees.
What is the HIMS 52-week high?
The 52-week high for HIMS is $65.30 and the 52-week low is $13.74. The stock is currently 54.8% below its high.